Font Size: A A A

CELL Series

Cancer Education Lunch & Learns

Join us online for live educational sessions tailored to fit your lunch hour. The CELL Series features talks from local and national experts on a variety of topics across the cancer continuum, great for clinical and public health professionals along with interested community members.

Attend the live sessions to participate in the Q&A or view the recorded sessions posted in our continuing education library. We will not be offering CME/CE credit for these sessions, but they are a great way to learn about new topics and ideas you may want to explore more.

Each session is from 12-12:45 p.m. and registration is required. See below for upcoming topics, dates, and details.

NEW: January 27, 2027: Finding the Eligible Patient for Lung Cancer Screening

Lung cancer screening with annual low-dose CT can save lives by detecting lung cancer at an earlier, more treatable stage. Yet many eligible individuals remain unscreened, often because smoking history is not consistently assessed or because eligibility conversations are challenging to incorporate into routine care. At the same time, patients and providers frequently ask why environmental risk factors such as secondhand smoke exposure, radon exposure and occupational exposures are not included in current screening eligibility criteria.

Register here

This webinar will review the current evidence-based eligibility recommendations for lung cancer screening, explain how the criteria were developed and discuss why certain environmental and occupational risk factors, while important contributors to lung cancer risk, are not currently used to determine screening eligibility. Participants will explore practical strategies for systematically identifying eligible patients through standardized tobacco use assessment, accurate pack-year documentation and electronic health record workflows. The session also will introduce principles of non-stigmatizing, patient-centered communication that encourage productive conversations about lung cancer risk and screening while reducing shame and blame associated with tobacco use.

Featuring:

Jamie L. Studts, PhD
Professor, Division of Medical Oncology, Department of Medicine, Program Co-Leader, Cancer Prevention and Control
University of Colorado School of Medicine

NEW: December 4, 2026: Hereditary Cancer Genetic Testing: Recognizing Risk and Guiding Patients to Care

Personal and family cancer histories can offer important clues about hereditary cancer risk, but knowing when and how to connect someone with genetics services can be challenging. This session will help clinical and community professionals recognize those clues, explain the role of genetic counseling, and support informed decisions about hereditary cancer genetic testing. We will discuss the benefits and limitations of testing, common misconceptions, and what different results may mean for patients and their relatives. Practical examples will highlight opportunities for referral, patient education, and follow-up.

Register

By the end of this session, participants will be able to:

  • Identify features of personal and family cancer histories that may warrant referral for genetic counseling and consideration of hereditary cancer genetic testing.
  • Describe the role of genetic counseling and the benefits, limitations, and possible results of hereditary cancer genetic testing.
  • Distinguish hereditary cancer genetic testing from direct-to-consumer testing and address common misconceptions.
  • Apply practical strategies to help patients access genetics services and appropriate follow-up care.

Our speaker:

Dr. Isha Kalia, PhD, MS, MPH, LCGC
Founder & Clinical Director·Open Helix Health

Dr. Isha Kalia is a Nevada-licensed genetic counselor and founder of Open Helix Health, a telehealth genetics practice serving adults throughout Nevada. She previously served as Director of the Genetics Program at the George Washington University Cancer Center in Washington, DC. Through Open Helix Health, she helps adults understand their personal and family health history, explore genetic testing options, and interpret existing genetic test results. A Las Vegas native, Dr. Kalia is committed to expanding access to genetic healthcare and providing practical, approachable education for patients, healthcare professionals, and community organizations.

November 4, 2026: Stronger through every stage, the role of cancer rehabilitation

In this webinar, Sarah Blount from Cancer Rehab Group will explore how rehabilitation supports patients throughout the cancer care continuum.

 

June 5, 2026: Lifestyle Medicine Across the Cancer Continuum

Lifestyle choices play a measurable role in cancer risk, treatment outcomes and survivorship. This webinar explores how lifestyle medicine is being used across the cancer continuum to address those factors with evidence-based strategies.

Participants will learn the six core pillars of lifestyle medicine and how they apply to chronic disease prevention and cancer risk reduction, with a focus on modifiable behaviors such as nutrition, physical activity, sleep, stress management, social connection and avoidance of harmful substances. The session will also examine how these approaches can support patients during and after treatment, including improving treatment tolerance, reducing side effects and enhancing quality of life.

The webinar will highlight how Renown Health is integrating lifestyle medicine into oncology care through its Oncology Wellness Clinic, offering a practical example of how health systems can embed prevention and survivorship strategies into clinical practice.

Designed for clinicians, public health professionals and community partners, this session provides actionable insights to help translate lifestyle medicine into real-world cancer care and survivorship support.

 

 

February 25, 2026: Understanding the Role of End-of-Life Doulas

Have you heard about end-of-life doulas, sometimes called death doulas? End-of-life doulas offer social-emotional wrap-around services related to planning for death, actively dying, and wrapping up affairs. They are increasing in numbers, filling in gaps and supporting patients, caregivers, and families. Melissa Chanselle-Hary, a northern Nevada-based end-of-life doula and owner of Sacred Transits, will share more about the role, bust myths about the field, and describe the ideal model of how an end-of-life doula can be integrated into a patient's care team.

March 12, 2025: Expanding Access to Cervical Cancer Screening: The Role of Self-Collection

Join us for a discussion on the emerging role of self-collection for cervical cancer screening and its potential to improve access, especially in rural and trauma-informed care settings. Learn about the SHIP Trial, how self-collection compares to traditional screening methods, and when we might expect to see broader implementation.

Featuring:

Deanna Kepka, PhD, MPH
College of Nursing & Huntsman Cancer Institute
University of Utah

April 16, 2025: The Future of Cancer Care: Innovative Oncology Advancements and Their Clinical Implications

This webinar will provide an overview of the Renown Health Office of Clinical Research and its oncology portfolio, offering participants insights into ongoing efforts to advance cancer care. Attendees will explore current trends in oncology treatment, focusing on how recent research findings are being applied to improve patient outcomes. The session will also examine future opportunities in cancer treatment, highlighting emerging innovations and their potential impact. Additionally, speakers will showcase one or two active clinical trials at Renown, detailing their objectives, methodologies, and significance in the broader context of oncology research.

Register here.

Featuring:

Harry Menon, DO, MPH, Medical Oncologist and Hematologist, William N. Pennington Cancer Institute at Renown Health

Kristen Gurnea, MPH, Director of Clinical Research, Renown Health

February 7, 2024: Using Nevada's Lung Screening Toolkit

Lung cancer is the leading cause of cancer death, but we have the opportunity to reduce late-stage diagnosis and reduce mortality through screening. Join us as we review the importance of a lung screening program and the toolkit NCC's Lung Cancer Collaborative developed to help get your lung screening program off the ground.

Featuring:

Lily Helzer, MPH, Cancer Prevention & Early Detection Programs Manager, Nevada Cancer Coalition

Jamie Studts, PhD, Professor of Medical Oncology, University of Colorado School of Medicine and Co-Leader of Cancer Prevention and Control, University of Colorado Cancer Center

 

February 28, 2024: HPV-Related Cancer Prevention for Dental Professionals

HPV-related head and neck cancers are quickly becoming the leading HPV-related cancer diagnosed in the U.S. Dentists and dental hygienists are often the first to discover these head and neck cancers during routine care. You have the power to reduce the incidence of HPV-related cancers and pre-cancers. The HPV vaccine is nearly 100% effective in preventing all HPV- related cancers, including head and neck cancers. Join us to explore how the dental community can prevent cancer.

Featuring:

Lily Helzer, MPH, Cancer Prevention & Early Detection Programs Manager, Nevada Cancer Coalition

Todd Landaburu, Cancer Survivor

Alice P. Chen, DMD, FAAPD
Roseman University of Health Sciences College of Dental Medicine
Associate Professor and Board Certified Pediatric Dentist

Civon Gewelber, DDS, MHA
Roseman University of Health Sciences College of Dental Medicine
Assistant Professor

March 20, 2024: Understanding the Role of Biomarkers in Personalized Healthcare for Cancer

Identifying biomarkers in a patient’s tumor tissue or blood is an essential step in developing a personalized treatment plan, which might include targeted medicines or immunotherapies. However, not all patients receive biomarker testing, or tests for all possible biomarkers. There are multiple reasons for today’s biomarker testing gaps, including lack of awareness, inadequate insurance coverage, and practical challenges such as long turn-around times for results. Learn more about biomarkers and biomarker testing in this fast-paced introduction session.

Featuring:

Carol Fier, MSN Principal Medical Science Liaison, Lung, GU and Derm Oncology, US Medical Affairs, Genentech

Emily Driver, PhD Senior Medical Science Liaison, Breast, GI, & Gynecological Oncology, US Medical Affairs, Genentech

Mary Halloran, PharmD, BCPS Principal Medical Science Liaison, Malignant Hematology, US Medical Affairs, Genentech

April 24, 2024: Skin Cancer Prevention

When caught early, skin cancer is highly treatable. But what do you even look for? Join us for a discussion about knowing your normal,  what changes indicate you need to look deeper, and how skin cancer impacts every skin tone. This presentation is for anyone interested in learning more about skin- for themselves, their families, their patients, and their communities. 

 

Featuring Dr. Whitney Hovenic.

Hovenic is a Double Board-Certified Dermatologist and Mohs Micrographic Dermatologic Surgeon with Skin Cancer and Dermatology Institute. She is happy to be back in Northern Nevada. A native of California, she graduated from the University of Nevada School of Medicine and completed her residency in dermatology at the University of Missouri. She practiced general dermatology at the University of Missouri before completing a fellowship in Mohs Micrographic Surgery and receiving extensive training in lasers and cosmetic dermatology at the University of California, Irvine. She is a community champion for skin cancer prevention and early detection and the force behind the Biggest Little Skin Cancer Screening to be hosted in Reno on May 7. Participants of this webinar are invited to also volunteer for the Biggest Little Skin Cancer Screening for additional learning experience.

 

June 5, 2024: Navigating Intimacy After Cancer

Cancer patients have been suffering in silence when it comes to sexual health issues after treatment. They are in need of anticipatory guidance, but the topic of sexual health is seldom addressed. In this session you'll get a taste of how to prioritize sexual health in oncology care and improve the quality of life for all those affected by cancer, from diagnosis through survivorship. This is the first step to help you normalize the conversation, set patient expectations, and refer patients timely.

This CELL Series session is a preview for a workshop planned for the Nevada Cancer Control Summit Aug. 23-24 in Reno. Attendees of this session will receive priority access to the longer workshop, which has limited space. We will add an additional workshop based on demand.

Featuring:

Amy Thompson, RN, OCN, CN-BN, Survivorship Programs Manager, Nevada Cancer Coalition

Erin Sullivan Wagner, Executive Director of After Cancer, Inc.

 

June 13, 2024: Diet and Lifestyle Guidelines for Prevention and Survivorship

In today’s technology-based society, it is easy to get misinformation or misinterpret nutrition guidelines. In this session, you will discover the latest evidenced-based recommendations for cancer prevention and survivorship. We will discuss actionable behavior modifications to reduce the risk for all cancers, while helping to identify resources online to assist with education and support groups for nutrition and physical activity.

Featuring: Karen Fisicaro, RD, LD, CSO, Clinical Dietitian/Nutrition Care Coordinator, Board Certified Specialist in Oncology Nutrition, Carson Tahoe Cancer Center

 

October 16, 2024: The Mountain West Community Health Assessment Survey

A first-ever survey conducted by Huntsman Cancer Institute at the University of Utah researchers reveals that residents in frontier areas of the Mountain West face significant barriers to health care. The Community Health Assessment Survey (CHAS) is the first of its kind to focus solely on patients in rural and frontier areas. Rural counties have fewer than 100 people per square mile while frontier areas have seven or fewer per square mile. The team, led by Tracy Onega, PhD, senior director of population sciences at Huntsman Cancer Institute, and professor of population sciences, found that most people living in rural and frontier counties know little to nothing about cancer clinical trials, considered to be the standard of cancer care by the American Society for Clinical Oncology.

Learn more about what the CHAS revealed, including Nevada-specific data, from Huntsman Cancer Institute's Bailee Daniels, MS, CCRC, a senior manager for Population Sciences and Community Outreach & Engagement.

 

November 6, 2024: Nevada's Central Cancer Registry

Cancer registries are vital parts of the cancer control and research worlds, providing invaluable data on cancer cases for every state. Join us to learn more about how the Nevada Central Cancer Registry collects and reports data, the role healthcare providers play in cancer data, electronic reporting, and how to request Nevada’s data.

Featuring:

Patience Gbafa, MPH,
Cancer Epidemiologist
Nevada Central Cancer Registry

Aundrea Ogushi
Manager
Nevada Central Cancer Registry